|
|
|
|
|
|
|
|
|
|
Blogger's Note: ovarian cancer patients will know only too well the results of being 'lumped into' clinical research findings which do not at all reflect their own personal situation; while recent research notes changes in treatments/clinical trial specifics to individuals, the reality is still that most patients are receiving 1st line treatments applicable to general research findings (we can use serous cell type as an example); aside from clinical trials, which the vast majority of patients do not enrol in (justifiable), we have a long way to go in this extraordinarily complex chain of events in patient diagnosis and treatments
~~~~~~~~~~~~~~~
Personalized Cancer Care: N-of-1
"...So what about an N-of-1? This disrupts every tenet of cancer research, upends every power analysis, and completely rewrites the book of developmental therapeutics. Every patient is his or her own control. Their good outcome reflects the success or failure of “the trial.” There is no power analysis. It is an “N” of 1."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.